Ratings by Baird (Michael Ulz)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/4/2021 Karyopharm Therapeutics KPTI Maintain Outperform
(N/A)
 
 
  Details
12/14/2020 Alexion Pharmaceuticals ALXN Downgrade Neutral
(Outperform)
118.87
(182.01)
53.12% Details
11/3/2020 Jounce Therapeutics JNCE Maintain Outperform
(N/A)
 
 
  Details
10/7/2020 iTeos Therapeutics ITOS New Coverage Outperform
(N/A)
21.59
(28.75)
33.16% Details
9/23/2020 Neoleukin Therapeutics NLTX New Coverage Outperform
(N/A)
12.30
(8.24)
-33.01% Details
8/20/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Outperform
(N/A)
 
 
  Details
8/19/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Outperform
(N/A)
 
 
  Details
8/12/2020 ORIC Pharamceuticals ORIC New Coverage Outperform
(N/A)
25.42
(25.22)
-0.79% Details
7/30/2020 Genocea Biosciences GNCA Maintain Outperform
(N/A)
 
 
  Details
7/24/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Outperform
(N/A)
 
 
  Details
7/17/2020 IGM Biosciences IGMS New Coverage Outperform
(N/A)
62.00
(74.82)
20.68% Details
7/14/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
6/1/2020 Harpoon Therapeutics HARP Maintain Outperform
(N/A)
 
 
  Details
6/1/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Outperform
(N/A)
 
 
  Details
4/29/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
4/16/2020 Atreca Inc. BCEL New Coverage Outperform
(N/A)
17.39
(6.29)
-63.83% Details
4/1/2020 Ultragenyx Pharma RARE Maintain Outperform
(N/A)
 
 
  Details
3/2/2020 Karyopharm Therapeutics KPTI Maintain Outperform
(N/A)
 
 
  Details
2/14/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
1/31/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
1/9/2020 Amicus Therapeutics FOLD Maintain Outperform
(N/A)
 
 
  Details
12/13/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Outperform
(N/A)
 
 
  Details
11/13/2019 Karyopharm Therapeutics KPTI Maintain Outperform
(N/A)
 
 
  Details
11/6/2019 Ultragenyx Pharma RARE Maintain Outperform
(N/A)
 
 
  Details
9/24/2019 Karyopharm Therapeutics KPTI Maintain Outperform
(N/A)
 
 
  Details
9/16/2019 Karyopharm Therapeutics KPTI Maintain Outperform
(N/A)
 
 
  Details
8/30/2019 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
8/2/2019 Coherus Biosciences CHRS Maintain Outperform
(N/A)
 
 
  Details
7/19/2019 Blueprint Medicines BPMC New Coverage Outperform
(N/A)
96.33
(106.00)
10.04% Details
7/5/2019 Karyopharm Therapeutics KPTI Maintain Outperform
(N/A)
 
 
  Details
7/5/2019 Karyopharm Therapeutics KPTI Maintain Outperform
(Outperform)
 
 
  Details
6/28/2019 argenx SE ARGX New Coverage Outperform
(N/A)
135.07
(331.67)
145.55% Details
6/19/2019 Coherus Biosciences CHRS Maintain Outperform
(N/A)
 
 
  Details
6/3/2019 Genocea Biosciences GNCA Maintain Outperform
(N/A)
 
 
  Details
4/26/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Outperform
(N/A)
 
 
  Details
4/23/2019 Harpoon Therapeutics HARP New Coverage Outperform
(N/A)
13.03
(8.75)
-32.85% Details
4/22/2019 Amicus Therapeutics FOLD Maintain Outperform
(N/A)
 
 
  Details
4/10/2019 Coherus Biosciences CHRS Maintain Outperform
(N/A)
 
 
  Details
4/2/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Outperform
(N/A)
 
 
  Details
3/28/2019 Proteon Therapeutics PRTO Maintain Neutral
(N/A)
 
 
  Details
2/28/2019 NewLink Genetics NLNK Maintain Neutral
(N/A)
 
 
  Details
2/27/2019 Karyopharm Therapeutics KPTI Maintain Outperform
(N/A)
 
 
  Details
1/28/2019 Constellation Pharmaceuticals CNST New Coverage Outperform
(N/A)
6.69
(20.24)
202.54% Details
1/4/2019 Mersana MRSN Maintain Outperform
(N/A)
 
 
  Details
1/2/2019 Genocea Biosciences GNCA Maintain Outperform
(N/A)
 
 
  Details
12/3/2018 Tesaro TSRO Maintain Neutral
(N/A)
 
 
  Details
11/7/2018 Paratek Pharmaceuticals PRTK Maintain Outperform
(N/A)
 
 
  Details
10/26/2018 Ultragenyx Pharma RARE Maintain Outperform
(N/A)
 
 
  Details
10/19/2018 Merrimack Pharmaceuticals MACK Maintain Neutral
(N/A)
 
 
  Details
9/26/2018 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
9/24/2018 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
9/21/2018 GTX Inc. GTXI Downgrade Neutral
(Outperform)
23.29
(1.20)
-94.85% Details
9/19/2018 Surface Oncology SURF New Coverage Outperform
(N/A)
10.24
(7.10)
-30.66% Details
8/15/2018 Mersana MRSN Maintain Outperform
(N/A)
 
 
  Details